Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Laforêt

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Revue Neurologique|April 6, 2006
[Therapeutic trials and muscular diseases]P Laforêt
La Revue De Medecine Interne|November 22, 2007
[Pompe's disease]P Laforêt
Revue Neurologique|September 25, 2016
What have we learned about glycogenosis in recent years?P Laforêt
Revue Neurologique|January 7, 2023
The new horizons for treatment of Late-Onset Pompe Disease (LOPD)C Guémy, P Laforêt
Revue Neurologique|March 23, 2004
[Exercise-intolerance and exercise-induced rhabdomyolisis: etiology and diagnosis]P Laforêt, B Eymard
La Revue De Medecine Interne|January 25, 2002
[Metabolic myopathies in adulthood. Features and clues for diagnosis]B Eymard, P Laforêt
Revue Neurologique|March 6, 2003
[A patient with suspected muscle disease?]B Eymard, P Laforêt
Revue Neurologique|February 2, 2023
Progress in hereditary neuropathies, myopathies and motoneuron disorders!J-P Camdessanché, P Laforêt
Revue Neurologique|November 23, 2007
[New approaches for the treatment of metabolic myopathies]P Laforêt, M Nicolino, B Eymard
Revue Neurologique|December 14, 2022
Gene therapy review: Duchenne muscular dystrophy case studyE Berling, R Nicolle, P Laforêt, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Revue Neurologique|April 6, 2006
[Therapeutic trials and muscular diseases]P Laforêt
La Revue De Medecine Interne|November 22, 2007
[Pompe's disease]P Laforêt
Revue Neurologique|September 25, 2016
What have we learned about glycogenosis in recent years?P Laforêt
Revue Neurologique|January 7, 2023
The new horizons for treatment of Late-Onset Pompe Disease (LOPD)C Guémy, P Laforêt
Revue Neurologique|March 23, 2004
[Exercise-intolerance and exercise-induced rhabdomyolisis: etiology and diagnosis]P Laforêt, B Eymard
La Revue De Medecine Interne|January 25, 2002
[Metabolic myopathies in adulthood. Features and clues for diagnosis]B Eymard, P Laforêt
Revue Neurologique|March 6, 2003
[A patient with suspected muscle disease?]B Eymard, P Laforêt
Revue Neurologique|February 2, 2023
Progress in hereditary neuropathies, myopathies and motoneuron disorders!J-P Camdessanché, P Laforêt
Revue Neurologique|November 23, 2007
[New approaches for the treatment of metabolic myopathies]P Laforêt, M Nicolino, B Eymard
Revue Neurologique|December 14, 2022
Gene therapy review: Duchenne muscular dystrophy case studyE Berling, R Nicolle, P Laforêt, et al.
Pageof 8